Search

Author/Creator Dubinsky Marla presenter.

1. S1028 Symptoms and Laboratory Values as Proxies for Endoscopic and Histologic Clinical Endpoints in Ulcerative Colitis: A Mediation Analysis Based on Upadacitinib Phase 3 Induction Trials. (October 2022)

Authors:
Yang, Min; Fillbrunn, Mirko; Danese, Silvio; Burisch, Johan; Tanida, Satoshi; Sharma, Dolly; Ilo, Dapo; Zhou, Wen; Sanchez-Gonzalez, Yuri; Peyrin-Biroulet, Laurent
Other Names:
Dubinsky Marla presenter.
Journal:
American journal of gastroenterology
Issue:
Volume 117:Number 10(2022)supplement 10S
Page Start:
e746
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. S714 52-Week Risankizumab Subcutaneous Maintenance Dosing Is Efficacious and Well Tolerated in Patients With Moderate to Severe Crohn's Disease Who Had Delayed Response to 12-Weeks IV Risankizumab Induction. (October 2022)

Authors:
D'Haens, Geert; Panaccione, Remo; Panés, Julian; Hisamatsu, Tadakazu; Bossuyt, Peter; Danese, Silvio; Neimark, Ezequiel; Song, Alexandra; Liao, Xiaomei; Wallace, Kori; Zambrano, Javier; Duan, W Rachel; Kligys, Kristina
Other Names:
Dubinsky Marla presenter.
Journal:
American journal of gastroenterology
Issue:
Volume 117:Number 10(2022)supplement 10S
Page Start:
e497
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search